Latest News and Press Releases
Want to stay updated on the latest news?
Featured Releases
-
VANCOUVER, British Columbia, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Photonic Inc., today announced a comprehensive approach to Quantum Resource Estimation (QRE) that fundamentally shifts how quantum...
Read More -
Tiny Health—leader in preventive, personalized microbiome health—launches new aging study and deepens partnerships with wellness and longevity programs.
Read More
-
Los Angeles, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Ken MacMillan met Judy while being treated for injuries sustained during the Vietnam War. As a nurse, Judy wouldn’t talk to him as anything other than...
-
PHILADELPHIA, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Brandywine Realty Trust (NYSE:BDN) announced today that its Board of Trustees has declared a quarterly cash dividend of $0.08 per common share and OP...
-
Arctic Gateway Group and Nunavut Sealink & Supply Inc. partner to reinforce Churchill’s role as an important resupply hub for Nunavut’s Kivalliq region
-
אבו דאבי, איחוד האמירויות הערביות וניו יורק, Dec. 10, 2025 (GLOBE NEWSWIRE) -- KraneShares, חברת ניהול נכסים גלובלית הידועה בגישה מובחנת לסין, לאקלים ולטכנולוגיות מתפתחות, הודיעה היום כי...
-
VANCOUVER, British Columbia, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Photonic Inc., today announced a comprehensive approach to Quantum Resource Estimation (QRE) that fundamentally shifts how quantum...
-
LOS ANGELES, Dec. 10, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Gauzy, Ltd., (“Gauzy” or the "Company") (NASDAQ: GAUZ) investors off a class action on behalf of investors that bought...
-
BALA CYNWYD, Pa., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason...
-
Three new Bachelors of the Politecnico di Milano, delivered entirely in English, in three cities
-
LONDON, 10 Dec. 2025 (GLOBE NEWSWIRE) -- This is the End of Day Message for GlobeNewswire. GlobeNewswire is operated by Notified and is designated by the FCA as an approved primary information...
-
Overall response rate (ORR) of 55% and median progression-free survival of 14.5 months in patients without TP53 gene mutation Phase 2 results presented at 2025 San Antonio Breast Cancer Symposium ...